TrialJournal of cancer research and clinical oncology2023

Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS).

Kohei Shitara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.